Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension study of everolimus for advanced neuroendocrine tumors
2012-001099-13Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in gastrointestinal neuroendocrine neoplasm (GI-NEN), apudoma (NET), sponsored by Novartis. Started May 2012; status: completed.
02
Drugs
everolimus
03
Conditions
gastrointestinal neuroendocrine neoplasm (GI-NEN)apudoma (NET)
Beyond the preview
Go deeper on 2012-001099-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001099-13.